3 results match your criteria: "Sumeru Hospital Pvt Ltd[Affiliation]"
Int J Biomater
November 2023
Department of Laboratory Medicine, Manmohan Memorial Institute of Health Sciences, Kathmandu, Nepal.
Background: Bacterial biofilm is a significant virulence factor threatening patients, leading to chronic infections and economic burdens. Therefore, it is crucial to identify biofilm production, its inhibition, and reduction. In this study, we investigated biofilm production among Gram-negative isolates and assessed the inhibitory and reduction potential of ethylene diamine tetra acetic acid (EDTA) and dimethyl sulfoxide (DMSO) towards them.
View Article and Find Full Text PDFAdv Med
October 2023
Department of Public Health, Manmohan Memorial Institute of Health Sciences, Kathmandu, Nepal.
Background: The global threat of COVID-19 has created the need for researchers to investigate the disease's progression, especially through the use of biomarkers to inform interventions. This study aims to assess the correlations of laboratory parameters to determine the severity of COVID-19 infection.
Methods: This study was conducted among 191 COVID-19 patients in Sumeru Hospital, Lalitpur, Nepal.
Open Med (Wars)
October 2023
Department of Pathology, Sumeru Hospital Pvt Ltd, Dhapakhel, Lalitpur, Nepal.
Identifying and appropriately managing urinary tract infections (UTIs) among chronic kidney disease (CKD) patients are essential to reduce further disease complications and economic burden. Hence, this study aims to determine the prevalence of UTIs among CKD patients and study the antibiogram of the bacterial isolates. Four hundred eighty-two clean catch midstream urine samples were collected from CKD patients during the study period.
View Article and Find Full Text PDF